Literature DB >> 19514127

A prime-boost vaccination of mice with heterologous H5N1 strains.

Daisuke Ikeno1, Kazuhiko Kimachi, Yasuhiro Kudo, Shuro Goto, Shigeyuki Itamura, Takato Odagiri, Masato Tashiro, Yoichiro Kino.   

Abstract

We evaluated the priming effect of an H5N1 pandemic vaccine in a mouse model to investigate strategies for influenza pandemic vaccination. For priming, an alum-adjuvanted inactivated whole H5N1 vaccine (NIBRG-14, clade 1) was used. As booster vaccines, several formulations of Indo05/05/2005(H5N1)PR8-IBCDC-RG2 vaccines (clades 2-1)were evaluated, including split, whole, alum-adjuvanted split, and alum-adjuvanted whole vaccines. Any type of booster vaccination elicited a significant HI antibody response despite the difference in antigenicity between the priming and booster vaccines. The split vaccine elicited a much stronger booster response than the alum-adjuvanted whole vaccine. When the mice were primed with the H1N1 or H3N2 vaccines, this did not affect the booster response to the H5N1 vaccine. These results indicated that an alum-adjuvanted whole vaccine is able to confer immunological memory to haemagglutinin even if the primed and boosted vaccine strains are in different clades and, once vaccinated, a split vaccine is preferred to evoke recall responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19514127     DOI: 10.1016/j.vaccine.2009.01.007

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

2.  Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus.

Authors:  Heng Ding; Cheguo Tsai; Ramona Alikiiteaga Gutiérrez; Fan Zhou; Philippe Buchy; Vincent Deubel; Paul Zhou
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

3.  Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines.

Authors:  Shih-Chang Lin; Ming-Hsi Huang; Pei-Chun Tsou; Li-Min Huang; Pele Chong; Suh-Chin Wu
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

4.  Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies.

Authors:  Alexandra Richard-Mazet; Sylvain Goutebroze; François-Xavier Le Gros; David E Swayne; Michel Bublot
Journal:  Vet Res       Date:  2014-10-30       Impact factor: 3.683

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.